Non-pegylated long-circulating liposomes

The present invention provides a long circulating non-pegylated liposomal doxorubicin hydrochloride composition for parenteral administration and a process for its preparation. The circulation time in Swiss albino mice is at least 25 times longer than conventional non-liposomal formulations. The non...

Full description

Saved in:
Bibliographic Details
Main Authors DAFTARY GAUTAM VINOD, RIVANKAR SANGEETA HANURMESH, PAI SRIKANTH ANNAPPA
Format Patent
LanguageEnglish
Published 14.04.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a long circulating non-pegylated liposomal doxorubicin hydrochloride composition for parenteral administration and a process for its preparation. The circulation time in Swiss albino mice is at least 25 times longer than conventional non-liposomal formulations. The non-pegylated liposomes are stable, exhibit low toxicity and have been found to be efficacious in different tumor models.
Bibliography:Application Number: US20080175125